McALLEN, Texas (Border Report) — A new study says U.S. and Mexican collaboration is essential to halting illegal immigration at the border, and it credits Mexico for helping to reduce crossings at the ...
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of targeted ...
Economic and public health conditions influence universities' research priorities. A study led by INGENIO, a joint research center of the Spanish National Research Council (CSIC) and the Universitat ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new research study sponsored by Tempus and ...
RIYADH, Saudi Arabia--(BUSINESS WIRE)--Artificial intelligence is quietly reshaping global transportation systems, but most deployments remain isolated pilots that haven't achieved scale – and the gap ...
Entered into an additional clinical study collaboration and supply agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with Trodelvy, Gilead's Trop-2 directed ADC, in ...
Tempus Launches Its First Study With a Nonprofit Foundation Collaborator to Create Robust FL Dataset Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision ...
Entered into Clinical Study Collaboration and Supply Agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with sacituzumab-govitecan-hziy ("Trodelvy") Gilead's Trop-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results